✦ LIBER ✦

R422 – EMMPRIN as a Novel Target in Head and Neck Cancer

✍ Scribed by Seena Safavy; Nichole Dean; John Robert Newman; Wenyue Zhang; David Michael Weeks; Emily E. Helman; Donald J. Buchsbaum; Eben L. Rosenthal

Book ID: 116814254
Publisher: SAGE Publications
Year: 2008
Tongue: English
Weight: 35 KB
Volume: 139
Category: Article
ISSN: 0194-5998
DOI: 10.1016/j.otohns.2008.05.576

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

STAT3 as a therapeutic target in head an

STAT3 as a therapeutic target in head and neck cancer

✍ Leeman, Rebecca J; Lui, Vivian Wai Yan; Grandis, Jennifer Rubin 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 547 KB

Identification of Metadherin as a Novel

Identification of Metadherin as a Novel Target of miR-375 in Head and Neck Cancer

✍ F. Liu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Epidermal growth factor receptor as a th

Epidermal growth factor receptor as a therapeutic target in head and neck cancer

✍ James A. Bonner; Jennifer De Los Santos; Harlan W. Waksal; Michael N. Needle; Ho 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Matrix metalloproteinase-2 as a target f

Matrix metalloproteinase-2 as a target for head and neck cancer therapy

✍ Chien, Ming-Hsien; Lin, Chiao-Wen; Cheng, Chao-Wen; Wen, Yu-Ching; Yang, Shun-Fa 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 527 KB

Mitochondria as a critical target of the

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer

✍ Kevin J. Cullen; Zejia Yang; Lisa Schumaker; Zhongmin Guo 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 195 KB

SP236 – miR-210 as a novel hypoxia marke

SP236 – miR-210 as a novel hypoxia marker in head and neck cancer

✍ Allen S. Ho; Xin Huang; Hongbin Cao; Quyhn-Thu Le 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 72 KB